rs80359351
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.
|
26026974 |
2015 |
rs80359351
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.
|
25476495 |
2015 |
rs80359351
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status.
|
24504028 |
2014 |
rs80359351
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
The highly prevalent BRCA2 mutation c.2808_2811del (3036delACAA) is located in a mutational hotspot and has multiple origins.
|
23929434 |
2013 |
rs80359351
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases.
|
22144684 |
2012 |
rs80359351
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.
|
22970155 |
2012 |
rs80359351
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
|
22006311 |
2011 |
rs80359351
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
EMMA, a cost- and time-effective diagnostic method for simultaneous detection of point mutations and large-scale genomic rearrangements: application to BRCA1 and BRCA2 in 1,525 patients.
|
21120943 |
2011 |
rs80359351
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients.
|
21952622 |
2011 |
rs80359351
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer.
|
21324516 |
2011 |
rs80359351
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.
|
23199084 |
2010 |
rs80359351
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.
|
20736950 |
2010 |
rs80359351
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.
|
19241424 |
2009 |
rs80359351
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting.
|
16683254 |
2006 |
rs80359351
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.
|
12955716 |
2003 |
rs80359351
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Protein truncating BRCA1 and BRCA2 mutations in African women with pre-menopausal breast cancer.
|
11030418 |
2000 |
rs80359351
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.
|
9585613 |
1998 |